Oncolytics Biotech

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ONCY and other ETFs, options, and stocks.

About ONCY

Oncolytics Biotech, Inc. engages in the development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolate of the reovirus that induce selective tumor lysis, and promotes an inflamed tumor phenotype through innate and adaptive immune responses. 

CEO
Matthew C. Coffey
CEOMatthew C. Coffey
Employees
26
Employees26
Headquarters
Calgary, Alberta
HeadquartersCalgary, Alberta
Founded
1998
Founded1998
Employees
26
Employees26

ONCY Key Statistics

Market cap
71.90M
Market cap71.90M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
46.98K
Average volume46.98K
High today
$1.27
High today$1.27
Low today
$1.23
Low today$1.23
Open price
$1.23
Open price$1.23
Volume
41.92K
Volume41.92K
52 Week high
$2.38
52 Week high$2.38
52 Week low
$0.8021
52 Week low$0.8021

ONCY Earnings

-$0.12
-$0.08
-$0.04
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 4
ActualExpected Nov 4
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.